Center-Authored Papers

Filters: Author is Fasching, Peter A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Z
W
White KL, Vierkant RA, Fogarty ZC, Charbonneau B, Block MS, Pharoah PDP, Chenevix-Trench G, Rossing MA, Cramer DW, Pearce CL et al..  2013.  Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 22(5):987-92. Abstract
S
Sucheston-Campbell LE, Cannioto R, Clay AI, Etter JL, Eng KH, Liu S, Battaglia S, Hu Q, Szender BJ, Minlikeeva A et al..  2016.  No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Abstract
P
Pearce CL, Stram DO, Ness RB, Stram DA, Roman LD, Templeman C, Lee AW, Menon U, Fasching PA, McAlpine JN et al..  2015.  Population distribution of lifetime risk of ovarian cancer in the United States.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 24(4):671-6. Abstract
O
N
M
L